Cargando…
RF16 | PSUN170 Prevalence of Fournier's Gangrene in T2DM Treated with Oral Antiglycemic Medications
INTRODUCTION: Sodium-glucose cotransporter 2 inhibitors (SGLT-2i) have become common pharmacotherapies in the treatment of type 2 diabetes mellitus. These agents are well described to increase the risk of genitourinary infections. Fournier's gangrene (FG), is a rare, life-threatening, necrotizi...
Autores principales: | Engel, Ashley, Carroll, Ty |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625313/ http://dx.doi.org/10.1210/jendso/bvac150.880 |
Ejemplares similares
-
PSUN259 A Severe Case of Fournier's Gangrene Associated With Dapagliflozin
por: Syed, Shumail, et al.
Publicado: (2022) -
RF16 | PSUN155 Empagliflozin and the risk of nephrolithiasis
por: Balasubramanian, Priyadarshini, et al.
Publicado: (2022) -
RF16 | PSUN177 Predictors of Postpartum Depressive Symptoms in Women with Recent GDM
por: Dias, Jennifer, et al.
Publicado: (2022) -
LBSUN291 Fournier's Gangrene In A Diabetic Male Taking Dapagliflozin
por: Patel, Janki M, et al.
Publicado: (2022) -
THU282 Improved Fournier’s Gangrene Outcomes With Prior SGLT2i Or Metformin Usage
por: Venugopal, Sharini, et al.
Publicado: (2023)